Neutrophil extracellular traps in the pathology of cancer and other inflammatory diseases

M Herre, J Cedervall, N Mackman… - Physiological …, 2023 - journals.physiology.org
Neutrophil extracellular trap (NET) formation, first described in 2004 as a previously
unknown strategy of neutrophils to fight microbes, has attracted an increasing interest in the …

NLRP3-Induced NETosis: a potential therapeutic target for ischemic thrombotic diseases?

R Kumar, G Patil, S Dayal - Cells, 2023 - mdpi.com
Ischemic thrombotic disease, characterized by the formation of obstructive blood clots within
arteries or veins, is a condition associated with life-threatening events, such as stroke …

ELISA detection of MPO-DNA complexes in human plasma is error-prone and yields limited information on neutrophil extracellular traps formed in vivo

H Hayden, N Ibrahim, J Klopf, B Zagrapan… - PLoS …, 2021 - journals.plos.org
Over the past years, neutrophil extracellular traps (NETs) were shown to contribute to states
of acute and chronic inflammatory disease. They are composed of expelled chromatin and …

[HTML][HTML] Histone citrullination as a novel biomarker and target to inhibit progression of abdominal aortic aneurysms

W Eilenberg, B Zagrapan, S Bleichert, N Ibrahim… - Translational …, 2021 - Elsevier
Neutrophil extracellular traps (NETs) have been implicated in the pathogenesis of
abdominal aortic aneurysms (AAAs). This study has addressed the notion that NET …

[HTML][HTML] Platelets and neutrophils cooperate to induce increased neutrophil extracellular trap formation in JAK2V617F myeloproliferative neoplasms

A Guy, G Garcia, V Gourdou-Latyszenok… - Journal of Thrombosis …, 2024 - Elsevier
Background Neutrophils participate in the pathogenesis of thrombosis through the formation
of neutrophil extracellular traps (NETs). Thrombosis is the main cause of morbidity and …

[HTML][HTML] Neutrophil extracellular traps and cancer-associated thrombosis

A Rosell, K Martinod, N Mackman, C Thålin - Thrombosis research, 2022 - Elsevier
The hypercoagulable state associated with malignancy is well described. However, the
mechanisms by which tumors cause this hypercoagulable state are yet to be fully …

Platelet toll-like receptors mediate thromboinflammatory responses in patients with essential thrombocythemia

CP Marín Oyarzún, AC Glembotsky, NP Goette… - Frontiers in …, 2020 - frontiersin.org
Essential thrombocythemia (ET) is comprised among chronic myeloproliferative neoplasms
(MPN) and is caused by driver mutations in JAK 2, CALR, and MPL, which lead to …

Pathogenesis of cardiovascular events in BCR-ABL1-negative myeloproliferative neoplasms

A Guy, J Poisson, C James - Leukemia, 2021 - nature.com
Thrombosis, both in arterial and venous territories, is the major complication of
myeloproliferative neoplasms and is responsible for a high rate of morbidity and mortality …

ROP-ET: a prospective phase III trial investigating the efficacy and safety of ropeginterferon alfa-2b in essential thrombocythemia patients with limited treatment …

JJ Kiladjian, FF Marin, HK Al-Ali, A Alvarez-Larrán… - Annals of …, 2024 - Springer
Interferon-based therapies, such as ropeginterferon alfa-2b have emerged as promising
disease-modifying agents for myeloproliferative neoplasms (MPNs), including essential …

Mechanisms of platelet activation in cancer-associated thrombosis: a focus on myeloproliferative neoplasms

RH Bekendam, K Ravid - Frontiers in Cell and Developmental Biology, 2023 - frontiersin.org
Platelets are anucleate blood cells that play key roles in thrombosis and hemostasis.
Platelets are also effector cells in malignancy and are known to home into the …